WELCOME TOACUPATH LABORATORIES
In-Network Processing
Acupath is a contracted, in-network provider for Medicare, most Medicaid HMO plans, and the majority of the leading commercial insurance plans:
COVID-19 Flu A & Flu B
The Acupath Difference – Our standard Covid-19 PCR assay detects all 3 genes as well as the Omicron variant and we now offer the addition of the Flu A & Flu B with one single swab.
Revenue Solutions
Available for physician offices, NYS Article 28 ASC’s, hospitals, and commercial laboratories. Scroll down or click box for more info.
Recent News
AllCancer AwarenessHealth ManagementPress ReleaseRespiratory Viruses
Meet our Executive and Laboratory leadership
Chief Sales Officer
John Cucci
John Cucci, a 15 year veteran of the anatomic pathology industry, joined Acupath in April 2015 as Director of Business Development and was promoted to Chief Sales Officer in January of 2017.
Chief Operating Officer
Brian Kunkel
Brian was named Chief Operating Officer in February 2021. Brian brings a wealth of experience to Acupath, having worked the laboratory business for many years, serving in leadership positions at Quest Diagnostics, ICON Clinical Trials, ProHealth, and New York Blood & Cancer.
Medical Director and Director of Molecular Genetics
Dr. Olga Falkowski
Dr. Falkowski serves as the Medical Director and Director of Molecular Genetics at Acupath Laboratories, Inc. where she is responsible for the supervision and sign out of histological, cytopathological, FISH (fluorescence in situ hybridization) and molecular cases.
Chief Financial Officer
Scott Ratafia
Scott Ratafia is an accomplished CFO known for his expertise in financial strategy, dynamic forecasting, and operational leadership. With a keen ability to drive growth and streamline operations, Scott brings a strategic edge to budgeting, forecasting, and process optimization, consistently delivering sustainable results and elevating business performance.
Accreditations and Affiliations
© 2024 Acupath Laboratories. All rights reserved